HOOD - Janux Therapeutics leads list of IPO stocks set to see lockup expirations this week

Drug developer Janux Therapeutics (NASDAQ:JANX) leads the list of about a half-dozen recent IPOs that will see their lockup expirations expire this week. Lockup expirations mark the first time that insiders, institutional investors and others who bought stocks at IPO or pre-IPO prices can sell their shares on the open market following a company’s initial public offering. The expirations often drive stocks’ prices down if insiders sell their shares, or can send a stock higher if they don’t. Here’s a look at the major IPO lockup expirations scheduled for this week: Monday, Dec. 6 Zhangmen Education (NYSE:ZME). ZME will face just the latest potentially negative catalyst when its lockup expires. The stock closed Friday at a record-low $1.10, down 6.8% on the day and 94.6% below the $20.52 intraday high the stock peaked at during its first post-IPO session in June. Zhangmen (ZME), which offers online tutoring to students in

For further details see:

Janux Therapeutics leads list of IPO stocks set to see lockup expirations this week